InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Atlas Venture Fund XI, L.P.. Officer active across 4 companies, notably Day One Biopharmaceuticals, Inc.. In total, 10 disclosures have been recorded. Total volume traded: €3.4m. The latest transaction was disclosed on 30 March 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations10 total
€2m125,000 shares@ €13.6477100.0% of flow
Common Stock
SEC:0001209191-21-069644·
Ideal exit: 25 Dec 2021 (T+270)
€2m125,000 shares@ €13.647750.0% of flow
Common Stock
SEC:0001209191-21-069644:0·
Ideal exit: 25 Dec 2021 (T+270)
0801,138 shares0
Common Stock
SEC:0001209191-21-067018·
0801,138 shares0
Common Stock
SEC:0001209191-21-067018:0·
1,372,998 shares
Common Stock
SEC:0001104659-21-130026·
1,372,998 shares
Common Stock
SEC:0001104659-21-130026:0·
0814,013 shares0
Common Stock
SEC:0001209191-21-046784·
0814,013 shares0
Common Stock
SEC:0001209191-21-046784:0·
7,761,380 shares
Common Stock
SEC:0001209191-21-037402·
7,761,380 shares
Common Stock
SEC:0001209191-21-037402:0·
10 of 10 declarations
About Atlas Venture Fund XI, L.P.
Atlas Venture Fund XI, L.P. serves as a director and insider for several companies, including Day One Biopharmaceuticals, Inc., Dyne Therapeutics, Inc., Xilio Therapeutics, Inc., and Ikena Oncology, Inc.
